Atorvastatin reduced coronary and stroke events in patients with hypertension and without dyslipidemia

March 2004
ACP Journal Club;Mar/Apr2004, Vol. 140 Issue 2, pA-16
Academic Journal
Presents letters to the editor. Comment on a study conducted by physician Joel A. Simon on the beneficial effects of atorvastatin in patients with hypertension and without dyslipidemia; Response to the critique on the study of the beneficial effects of atorvastatin.


Related Articles

  • Lowest statin dose counterproductive. Abd-Mariam, Nassif; MacSween, Alasdair; Booth, Philip // Pulse;3/22/2004, Vol. 64 Issue 12, p26 

    Presents a letter to the editor discussing the counterproductiveness of lowest dose of statin administered for the secondary prevention of coronary heart disease.

  • Variations and increase in use of statins across Europe: data from administrative databases. Walley, Tom; Folino-Gallo, Pietro; Schwabe, Ulrich; van Grease, Eric // BMJ: British Medical Journal (International Edition);2/14/2004, Vol. 328 Issue 7436, p385 

    Reports on the use of statins across Europe. Relation between the use of statins and lower blood cholesterol and reduced risk of coronary attacks; Details of the study; Extent of statin use across Europe; Results of analysis showing an enormous variation in statin use across Europe and a rapid...

  • GP Registrar: CHD prevention - part one. Newson, Louise // GP: General Practitioner;8/2/2004, p35 

    In July 2000 fewer than 40 per cent of secondary prevention patients in first-wave practices in the primary care collaborative for CHD were taking statins, compared to almost 70 per cent two years later. There is plenty of evidence to support prescribing ACE inhibitors for the secondary...

  • Age, sex and practice variations in the use of statins in general practice in England and Wales. Majeed, Azeem; Moser, Kath; Maxwell, Roy // Journal of Public Health Medicine;Sep2000, Vol. 22 Issue 3, p275 

    Background. Statins are highly effective in reducing the risk of sudden cardiac death and other acute coronary events in patients with pre-existing ischaemic heart disease or with raised blood cholesterol levels. However, relatively little is known about how statins are used in primary care. The...

  • Statins and the Reduction of Sudden Cardiac Death: Antiarrhythmic or Anti-Ischemic Effect? Beri, Abhimanyu; Contractor, Tahmeed; Khasnis, Atul; Thakur, Ranjan // American Journal of Cardiovascular Drugs;2010, Vol. 10 Issue 3, p155 

    Sudden cardiac death is an important cause of cardiovascular mortality with the majority of cases occurring in low-risk groups. HMG-CoA reductase inhibitors (statins) have recently been shown to reduce the incidence of ventricular tachycardia (VT)/fibrillation (VF) and sudden cardiac death, and...

  • Research. Accalai, Paola // Practice Nurse;2/23/2007, Vol. 33 Issue 4, p30 

    The article presents key findings from various clinical research. According to U.S. researchers, physical activity does not influence the risk of knee osteoarthritis. A Canadian meta-analysis suggests that intensive versus moderate statin therapy does not lower all-cause mortality in patients...

  • High-Dose Statin Therapy, Value for Older Adults. Elliott, William T. // OB/GYN Clinical Alert;Sep2007, Vol. 24 Issue 5, p1 

    The article reports on the effectiveness of aggressive lipid lowering with high-dose statin therapy for older patients with stable coronary disease based on a study conducted in the U.S. Patients who received low-dose atorvastatin had cholesterol levels of 100 mg/dl compared to 70 mg/dl for high...

  • Lipid management in TYPE 2 DIABETES. Turner, Alison // Practice Nurse;2/11/2005, Vol. 29 Issue 3, p46 

    Focuses on lipid lowering treatment for type 2 diabetics. Risk of developing a first cardiac event in patients; Criteria that must be met by patients to participate in the Collaborative Atorvastatin in Diabetes Study; Effectiveness of atorvastatin with placebo for reducing the risk of coronary...

  • Prevention of coronary heart disease. Taylor, David; Jenkins, Arnold; Conradi, Philipp // BMJ: British Medical Journal (International Edition);2/14/2004, Vol. 328 Issue 7436, p404 

    Presents a letter to the editor regarding the effectiveness of statins in preventing coronary heart disease.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics